Table 1

Description of the sample at baseline and follow-up

Variables  Baseline (n=606)*Follow-up (n=214)*
[% (n)][% (n)]
Categorical variables
Ethnicity
 White54.5 (330)65.9 (141)
 Asian18.2 (110)17.8 (38)
 Black12.7 (77)3.3 (7)
 Other11.2 (68)11.7 (25)
Religion
 Christian40.1 (243)38.3 (82)
 None33.0 (200)36.4 (78)
 Muslim13.4 (81)16.4 (35)
 Other11.2 (68)8.4 (18)
Someone close diagnosed with cancer?
 No35.5 (215)36.4 (78)
 Yes61.6 (373)62.1 (133)
Someone close diagnosed with cervical cancer?
 No88.4 (536)90.7 (194)
 Yes8.4 (51)7.9 (17)
Smoking status
 No77.1 (467)86.4 (185)
 Yes19.8 (120)12.6 (27)
Entitled to EMA?
 No (high-income household)51.8 (314)62.1 (133)
 Yes (low- income household)44.6 (270)36.0 (77)
Sexually active
 No56.4 (342)62.1 (133)
 Yes41.3 (250)35.5 (76)
Age of sexual debut
 16 years and above20.1 (122)16.4 (35)
 15 years and below20.6 (125)19.2 (41)
Intention
 High67.2 (407)75.2 (161)
 Low32.8 (199)24.8 (53)
Continuous variablesαRangeMean (SD)Mean (SD)
HPV knowledge0.720–158.00 (3.18)8.87 (2.96)
Positive vaccine attitude0.690–129.76 (1.85)10.17 (1.45)
Needle fear0–41.82 (1.46)1.63 (1.46)
Parental acceptance0–43.13 (0.91)3.28 (0.79)
Normative beliefs about HPV vaccine
 Friends0–42.80 (0.87)2.83 (0.76)
 Parent0–42.91 (0.95)3.02 (0.85)
Vaccine safety0–42.66 (0.68)2.78 (0.63)
Vaccine effectiveness against:
 HPV0–42.56 (0.66)2.87 (0.61)
 Cervical cancer0–42.72 (0.64)2.67 (0.65)
 Sexually transmitted infections0–41.67 (0.95)1.58 (1.00)
Perceived severity of:
 HPV0.950–127.60 (2.73)7.73 (2.86)
 Cervical cancer0.970–1210.22 (2.30)10.43 (2.17)
Perceived susceptibility to:
 HPV0–42.31 (0.87)2.31 (0.88)
 Cervical cancer0–42.29 (0.87)2.28 (0.84)
Discussing sex with parents0.830–42.14 (2.74)2.20 (1.53)
  • *Note that n varies slightly between items because of missing data.

  • EMA, Educational Maintenance Allowance; HPV, human papillomavirus; SD, standard deviation.